Zacks: Analysts Anticipate Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) to Announce $0.61 EPS

Retrieved on: 2021-04-23 14:42:48

Tags for this article:

Click the tags to see associated articles and topics

Zacks: Analysts Anticipate Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) to Announce $0.61 EPS. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 2,418,580 shares of the company's stock worth $119,744,000 after purchasing an additional 72,823 shares during the last ...

Article found on: www.marketbeat.com